AAAAAA
Results:
1-8
|
Results: 8
Authors:
SEGELOV E
MANN G
DEFAZIO A
HARNETT PR
Citation: E. Segelov et al., MECHANISMS DETERMINING SENSITIVITY TO CISPLATIN IN 3 MUTANT CHINESE-HAMSTER OVARY CELL-LINES, Mutation research. DNA repair, 407(3), 1998, pp. 243-252
Authors:
SEGELOV E
MANN GJ
HARNETT PR
Citation: E. Segelov et al., CHARACTERIZATION OF A NOVEL CISPLATIN-SENSITIVE MAMMALIAN MUTANT-CELLLINE, Journal of cellular biochemistry, 1995, pp. 286-286
Authors:
COATES AS
SEGELOV E
Citation: As. Coates et E. Segelov, LONG-TERM RESPONSE TO CHEMOTHERAPY IN PATIENTS WITH VISCERAL METASTATIC MELANOMA, Annals of oncology, 5(3), 1994, pp. 249-251
Authors:
SEGELOV E
FRIEDLANDER M
Citation: E. Segelov et M. Friedlander, PROGNOSTIC FACTORS FOR WOMEN WITH OVARIAN GERM-CELL TUMORS - REPLY, Journal of clinical oncology, 12(8), 1994, pp. 1738-1738
Authors:
SEGELOV E
CAMPBELL J
NG M
TATTERSALL M
ROME R
FREE K
HACKER N
FRIEDLANDER ML
Citation: E. Segelov et al., CISPLATIN-BASED CHEMOTHERAPY FOR OVARIAN GERM-CELL MALIGNANCIES - THEAUSTRALIAN EXPERIENCE, Journal of clinical oncology, 12(2), 1994, pp. 378-384
Authors:
SEGELOV E
COX KM
RAGHAVAN D
MCNEIL E
LANCASTER L
ROGERS J
Citation: E. Segelov et al., THE IMPACT OF HISTOLOGICAL REVIEW ON CLINICAL MANAGEMENT OF TESTICULAR CANCER, British Journal of Urology, 71(6), 1993, pp. 736-738
Authors:
SEGELOV E
RAGHAVAN D
COATES A
KRONENBERG H
Citation: E. Segelov et al., ACUTE-LEUKEMIA FOLLOWING CHEMOTHERAPY INCLUDING ETOPOSIDE FOR TESTICULAR-CARCINOMA, Australian and New Zealand Journal of Medicine, 23(6), 1993, pp. 718-719
Authors:
LEWIS CR
SEGELOV E
GOLDSTEIN D
FRIEDLANDER ML
Citation: Cr. Lewis et al., CHEMOTHERAPY MADE EASIER, Australian and New Zealand Journal of Medicine, 23(4), 1993, pp. 387-392
Risultati:
1-8
|